Science News

BrightFocus grantee Rik Ossenkoppele, PhD, of Vrije Universiteit (VU) Medical Center, Amsterdam, wins the Young Investigator Award at the 2016 Human Amyloid Imaging (HAI) Conference. Read more...

BrightFocus expert contributor, Yvonne Ou, MD, weighs in on eye drops, conventional surgery, and laser as treatment options in glaucoma. Read our Q and A.

Learn about an exciting gene editing technique that may one day be used in combination with cell regeneration to correct a genetic mutation leading to blindness.

Congratulations to former BrightFocus grantee Joel S. Schuman, MD, who has been appointed chair of ophthalmology at New York University's Langone Medical Center in New York City. Previously he was professor and chair of ophthalmology at the University of Pittsburgh Medical Center (UPMC) and director of the UPMC Eye Center

Read how Donald Zack, a past BrightFocus grantee, has been advancing cures for glaucoma and macular degeneration.

A research team, supported in part by BrightFocus Foundation, wanted to know whether patients who received the drug L-DOPA as treatment for Parkinson’s or other diseases were protected from AMD. After combing through massive amounts of medical chart data, their answer is yes.

BrightFocus Foundation applauds the three lifelong researchers who won this year’s Nobel Prize in chemistry, and commends the Nobel committee for its selections.

BrightFocus-funded grantees have shown how a bad form of tau, a protein that is a major player Alzheimer’s disease, may spread throughout the brain.